Unispital Basel
Welcome,         Profile    Billing    Logout  
 4 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Refardt, Julie
EMPOWER, NCT04447911: Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

Recruiting
4
172
Europe
Empagliflozin 25 MG, Placebo
University Hospital, Basel, Switzerland, Luzerner Kantonsspital, Centre Hospitalier Universitaire Vaudois
Hyponatremia, SIADH, Liver Failure, Kidney Failure
01/26
02/26
NCT03557957: Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia

Active, not recruiting
N/A
2278
Europe, RoW
Targeted correction of plasma sodium levels, Standard care
University Hospital, Basel, Switzerland, Erasmus Medical Center, Cantonal Hospital of Aarau, Switzerland, Spital Solothurn, Switzerland, Kantonsspital St. Gallen, Switzerland, Kantonsspital Liestal, Switzerland, Uniklinik Köln, Germany, KBC Zagreb, Croatia, Azienda Ospedaliero Universitaria Careggi, Italy
Hyponatremia
04/25
04/25
ESCAPE, NCT06277336: Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD

Recruiting
N/A
20
Europe
Placebo, Apelin Low Dose, Apelin High Dose, Selected Apelin Dose
University Hospital, Basel, Switzerland
SIAD - Syndrome of Inappropriate Antidiuresis, Hyponatremia
12/24
12/25
LUMEN1, NCT05605587: Leflunomide Treatment for MEN1 Patients - the Trial

Recruiting
N/A
15
Europe
Leflunomide 20 mg
University Hospital, Basel, Switzerland
MEN1 Gene Mutation
01/26
01/26
Kristoffersen, Espen Saxhaug
DO-IT, NCT06571149: Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Not yet recruiting
4
906
Europe, Canada, Japan, RoW
Tenecteplase or Alteplase
Insel Gruppe AG, University Hospital Bern
Ischemic Stroke
01/29
04/29
ELAN, NCT03148457: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Completed
N/A
2013
Europe, Japan, RoW
Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®), Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Insel Gruppe AG, University Hospital Bern
Ischaemic Stroke
12/22
05/23
DO-IT Cohort, NCT06556446: Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Recruiting
N/A
2800
Europe, Canada, RoW
Tenecteplase and Alteplase
Insel Gruppe AG, University Hospital Bern, Swiss Stroke Trialist Association, Swiss Stroke Registry
Ischemic Stroke
03/26
12/26
BioCer, NCT05616741: Home-based Biofeedback for the Prevention of Migraine

Completed
N/A
280
Europe
Cerebri biofeedback, Cerebri headache diary
Nordic Brain Tech AS, Norwegian University of Science and Technology, St. Olavs Hospital, University Hospital, Akershus, Haukeland University Hospital, University Hospital of North Norway
Migraine
09/24
09/24
NoCVT, NCT05021198: The Norwegian Cerebral Venous Thrombosis Study

Recruiting
N/A
600
Europe
University Hospital, Akershus, Oslo University Hospital, Haukeland University Hospital, Drammen sykehus, Sorlandet Hospital HF, St. Olavs Hospital, Nordlandssykehuset HF, University Hospital of North Norway, University of Oslo, Rigshospitalet, Denmark, Hospital de Santa Maria, Portugal, Sykehuset Innlandet HF, Molde Hospital, Helse Stavanger HF, Sykehuset Telemark, Sykehuset i Vestfold HF
Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
12/26
01/27
ASIST-1, NCT05378490: The Akershus Study of Ischemic Stroke and Thrombolysis -1

Recruiting
N/A
6000
Europe
University Hospital, Akershus, University of Oslo, Oslo University Hospital
Stroke, Acute, Intracerebral Hemorrhage, Stroke, Ischemic, TIA
12/25
12/40

Download Options